A new model of patient tumor-derived breast cancer xenografts for preclinical assays.
about
Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted TherapyHistological and molecular evaluation of patient-derived colorectal cancer explantsMolecular profiling of patient-derived breast cancer xenograftsPatient-derived tumour xenografts as models for oncology drug developmentEndocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenograftsPatient-derived tumor xenografts: transforming clinical samples into mouse modelsTumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomesPatient-derived xenograft models of colorectal cancer in pre-clinical research: a systematic reviewBioengineering Models for Breast Cancer ResearchAn Integrative Approach to Precision Cancer Medicine Using Patient-Derived XenograftsPatient-derived xenograft models to improve targeted therapy in epithelial ovarian cancer treatmentPatient-derived xenograft models of breast cancer and their predictive powerVandetanib as a potential new treatment for estrogen receptor-negative breast cancers.Patient-derived xenografts: a relevant preclinical model for drug developmentGenetically engineered mouse models in oncology research and cancer medicinePatient-derived tumour xenografts for breast cancer drug discoveryPrioritizing therapeutic targets using patient-derived xenograft modelsA phenotypic mouse model of basaloid breast tumorsEstablishment, characterization and chemosensitivity of three mismatch repair deficient cell lines from sporadic and inherited colorectal carcinomasLoss of p53 partially rescues embryonic development of Palb2 knockout mice but does not foster haploinsufficiency of Palb2 in tumour suppressionTranslational validation of personalized treatment strategy based on genetic characteristics of glioblastomaIn search of the molecular mechanisms mediating the inhibitory effect of the GnRH antagonist degarelix on human prostate cell growthAppropriateness of using patient-derived xenograft models for pharmacologic evaluation of novel therapies for esophageal/gastro-esophageal junction cancersCharacterization of Breast Cancer Preclinical Models Reveals a Specific Pattern of Macrophage PolarizationA Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer CompoundsReversible p53 inhibition prevents cisplatin ototoxicity without blocking chemotherapeutic efficacyIn vivo photoacoustic tomography of EGFR overexpressed in hepatocellular carcinoma mouse xenograft.Metastasis Research Society-American Association For Cancer Research Joint Conference on Metastasis.Risk of hormone escape in a human prostate cancer model depends on therapy modalities and can be reduced by tyrosine kinase inhibitorsIn vivo models in breast cancer research: progress, challenges and future directions.Modeling platinum sensitive and resistant high-grade serous ovarian cancer: development and applications of experimental systems.Current status and perspectives of patient-derived xenograft models in cancer research.Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition.Selective gene-expression profiling of migratory tumor cells in vivo predicts clinical outcome in breast cancer patients.microRNA-148a dysregulation discriminates poor prognosis of hepatocellular carcinoma in association with USP4 overexpression.Melatonin exerts anti-oral cancer effect via suppressing LSD1 in patient-derived tumor xenograft models.Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasisStability of preclinical models of aggressive renal cell carcinomas."A novel in vivo model for the study of human breast cancer metastasis using primary breast tumor-initiating cells from patient biopsies".Patient-derived xenograft models: an emerging platform for translational cancer research
P2860
Q21131727-409BD46B-7237-4F88-BE71-79428E6C51C9Q21134541-0B410B21-B12D-45A3-9FD1-F7A1EC894812Q21195204-7B124A02-D0E2-4DE9-A206-03BE017D7292Q24604068-1230F6B4-3FA8-44A5-A499-6BD65F956DC3Q24621116-1A332B5D-7E21-4375-A352-832EA847E287Q24627425-D1964199-5296-47D5-BD52-78434E10E2E7Q24630783-6E4F52C3-BAF3-4035-8083-9EDCDE743043Q26741651-C97FA81A-0F33-4D29-BD50-1F01F27ABCBAQ26770495-B2F9CA03-61E3-469A-9E1E-E51B2D69535FQ26772895-CEC15307-97A8-449E-8145-A5FA0EB35B1DQ26829125-5A2B96D5-9EFE-442A-B8DC-D8B2FB396883Q27026531-A4AAF909-5307-458B-9A8B-B208D886C8FBQ27853297-F9383966-04DF-47BC-873A-D2356FE30674Q28067191-6BB42DBA-4F57-4146-BDF2-5F7B8157AAD7Q28079323-EA6FED55-1758-40A2-AC25-2C5228284BC4Q28080046-774BE909-5979-485F-B427-68404432AA2CQ28083993-B27FB9F9-37BB-4169-9F5C-E56647954700Q28480588-E868696F-B3FB-4F8C-926E-108D8D4948BFQ28484668-A530F1E9-A3E7-480F-A14A-8E732211B1D4Q28512158-04E27171-1AD9-46ED-BB2D-56DE35203138Q28541502-6EB35EBC-BACB-4085-90D7-872F638C6372Q28545022-C5130AF5-3A34-4BAE-BB32-04B1FABB56CBQ28545204-FA57BA68-5216-4732-8A86-F77F20BE502EQ28552410-0B78B0AB-1EDE-4D53-90F3-736812876084Q28598343-366CB7A9-1893-488E-B676-8FE5983D7C4EQ30366115-23471B4B-4BFE-458C-8643-59527DA48539Q30372076-662A3E11-2B76-4ACF-8859-97269A30C8FDQ30437720-16884B1A-41CD-4BC9-AE9E-DF6CA40B58C1Q31081891-F0507F1F-5D0A-44CC-8560-B08AD10459CEQ33588117-47FD37C8-2FE5-4386-9957-FEA8D448D707Q33641924-E78C3B78-C3C8-4AC1-9357-17A9E162CF5BQ33667686-EC3507BE-F401-4D1A-9CBF-897FCC17356AQ33739184-3F99D6BA-1D8B-4A91-9CCD-656D7893A910Q33739307-99C94344-01F9-4A0C-81A4-F126FCD5C0DFQ33757112-D63DB3D8-3779-43BA-8DC0-99588888D5F8Q33779673-2233D9F5-D848-4DA8-ABC6-1DD3048CEF95Q33827461-26BF0CEC-8466-48DA-BFE4-17D726E00FDAQ33898564-09D82DE0-F0F2-41EF-B15D-6E8BD9FC575BQ34122934-98E61E63-D8B4-4C61-947E-F75407935EC1Q34205518-798D2AFF-5FFA-4B3F-B418-64F0081180C9
P2860
A new model of patient tumor-derived breast cancer xenografts for preclinical assays.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
A new model of patient tumor-derived breast cancer xenografts for preclinical assays.
@en
type
label
A new model of patient tumor-derived breast cancer xenografts for preclinical assays.
@en
prefLabel
A new model of patient tumor-derived breast cancer xenografts for preclinical assays.
@en
P2093
P50
P1476
A new model of patient tumor-derived breast cancer xenografts for preclinical assays.
@en
P2093
Armelle Degeorges
Brigitte Sigal-Zafrani
Carine Tran-Perennou
Charlotte Guyader
Elisabetta Marangoni
Franck Assayag
Gonzague De Pinieux
Jean-Gabriel Judde
Ludmilla de Plater
Magali Rebucci
P304
P356
10.1158/1078-0432.CCR-07-0078
P407
P50
P577
2007-07-01T00:00:00Z